Article Information
History
- October 24, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Meng Shi1,#,
- Jiaqi Zhao1,#,
- Mengfei Li2,#,
- Wei Huang1,
- Xue Bai1,
- Wenxue Zhang3,
- Kai Zhang1,
- Xuefeng Chen2,* and
- Song Xiang1,*
- 1Department of Biochemistry and Molecular Biology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The province and ministry co-sponsored collaborative innovation center for medical epigenetics, Tianjin Medical University, Tianjin 300070, P. R. CHINA
- 2Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Frontier Science Centre of Immunology and Metabolism, Wuhan University, Wuhan 430072, P. R. CHINA
- 3Department of Radiation Oncology, Tianjin Medical University General Hospital, Tianjin 300052, P. R. CHINA
- ↵*Correspondence for XC, xfchen{at}whu.edu.cn; for SX, xiangsong{at}tmu.edu.cn
↵# Equal contribution authors
Posted October 24, 2022.
